{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["30(10)"],"submitter":["Pawlowski C"],"pubmed_abstract":["<h4>Objective</h4>To assess the association of COVID-19 vaccines and non-COVID-19 vaccines with cerebral venous sinus thrombosis (CVST).<h4>Materials and method</h4>We retrospectively analyzed a cohort of 771,805 vaccination events across 266,094 patients in the Mayo Clinic Health System between 01/01/2017 and 03/15/2021. The primary outcome was a positive diagnosis of CVST, identified either by the presence of a corresponding ICD code or by an NLP algorithm which detected positive diagnosis of CVST within free-text clinical notes. For each vaccine we calculated the relative risk by dividing the incidence of CVST in the 30 days following vaccination to that in the 30 days preceding vaccination.<h4>Results</h4>We identified vaccination events for all FDA-approved COVID-19 vaccines including"],"journal":["Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association"],"pagination":["105923"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC8494567"],"repository":["biostudies-literature"],"pubmed_title":["Cerebral Venous Sinus Thrombosis is not Significantly Linked to COVID-19 Vaccines or Non-COVID Vaccines in a Large Multi-State Health System."],"pmcid":["PMC8494567"],"pubmed_authors":["Lenehan P","Swift MD","Pawlowski C","Venkatakrishnan AJ","Rincon-Hekking J","O'Horo JC","Virk A","Pandey V","Soundararajan V","Halamka J","Bade S","Gores GJ","Awasthi S","Williams AW","Badley AD"],"additional_accession":[]},"is_claimable":false,"name":"Cerebral Venous Sinus Thrombosis is not Significantly Linked to COVID-19 Vaccines or Non-COVID Vaccines in a Large Multi-State Health System.","description":"<h4>Objective</h4>To assess the association of COVID-19 vaccines and non-COVID-19 vaccines with cerebral venous sinus thrombosis (CVST).<h4>Materials and method</h4>We retrospectively analyzed a cohort of 771,805 vaccination events across 266,094 patients in the Mayo Clinic Health System between 01/01/2017 and 03/15/2021. The primary outcome was a positive diagnosis of CVST, identified either by the presence of a corresponding ICD code or by an NLP algorithm which detected positive diagnosis of CVST within free-text clinical notes. For each vaccine we calculated the relative risk by dividing the incidence of CVST in the 30 days following vaccination to that in the 30 days preceding vaccination.<h4>Results</h4>We identified vaccination events for all FDA-approved COVID-19 vaccines including","dates":{"release":"2021-01-01T00:00:00Z","publication":"2021 Oct","modification":"2025-04-04T20:12:41.45Z","creation":"2022-02-11T12:06:02.132Z"},"accession":"S-EPMC8494567","cross_references":{"pubmed":["34627592"],"doi":["10.1016/j.jstrokecerebrovasdis.2021.105923"]}}